Idorsia Ltd. (IDRSF)
7.25
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Idorsia Gross Profit Margin (Quarterly) : 72.13% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 72.13% |
| March 31, 2026 | 79.41% |
| December 31, 2025 | 72.02% |
| September 30, 2025 | 76.28% |
| June 30, 2025 | 88.48% |
| March 31, 2025 | 88.51% |
| December 31, 2024 | 59.78% |
| September 30, 2024 | 34.08% |
| June 30, 2024 | 69.05% |
| March 31, 2024 | 26.71% |
| December 31, 2023 | 79.35% |
| September 30, 2023 | 89.45% |
| June 30, 2023 | 73.62% |
| March 31, 2023 | 74.23% |
| December 31, 2022 | 84.38% |
| September 30, 2022 | 68.04% |
| June 30, 2022 | 66.18% |
| March 31, 2022 | -0.17% |
| Date | Value |
|---|---|
| December 31, 2021 | 12.56% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 87.80% |
| AC Immune SA | 0.00% |
| CRISPR Therapeutics AG | -337.8% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -67.29% |
| Return on Invested Capital | -209.4% |
| Profit Margin (Quarterly) | -202.5% |
| Operating Margin (Quarterly) | -68.77% |
| Return on Net Operating Assets | -90.33% |